Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth Berry-Kravis

Showing results (171-180 of 265) with videos related to

Pageof 27
Sort By:
Pediatrics|January 2, 2009
Advances in the treatment of fragile X syndromeRandi J Hagerman, Elizabeth Berry-Kravis, Walter E Kaufmann, et al.
Journal of Neurodevelopmental Disorders|June 30, 2010
Aging in fragile X syndromeAgustini Utari, Evan Adams, Elizabeth Berry-Kravis, et al.
Frontiers in Genetics|June 6, 2018
Health Profiles of Mosaic Versus Non-mosaic <i>FMR1</i> Premutation Carrier Mothers of Children With Fragile X SyndromeMarsha R Mailick, Arezoo Movaghar, Jinkuk Hong, et al.
Journal of Neurodevelopmental Disorders|November 26, 2022
A randomized, controlled trial of ZYN002 cannabidiol transdermal gel in children and adolescents with fragile X syndrome (CONNECT-FX)Elizabeth Berry-Kravis, Randi Hagerman, Dejan Budimirovic, et al.
Brain Sciences|December 19, 2018
Best Practices in Fragile X Syndrome Treatment DevelopmentCraig A Erickson, Walter E Kaufmann, Dejan B Budimirovic, et al.
Neurology|February 26, 2020
Validation of the NIH Toolbox Cognitive Battery in intellectual disabilityRebecca H Shields, Aaron J Kaat, Forrest J McKenzie, et al.
Journal of Neurodevelopmental Disorders|January 25, 2025
A randomized, placebo-controlled, cross-over trial of ketamine in Rett syndromeKathleen Campbell, Jeffrey L Neul, David N Lieberman, et al.
Journal of Child and Adolescent Psychopharmacology|February 6, 2025
The Aberrant Behavior Checklist for Fragile X Syndrome: A Qualitative Clinician Evaluation of Content ValidityLindsay M Oberman, Elizabeth Berry-Kravis, Dejan B Budimirovic, et al.
Molecular Genetics and Metabolism|July 30, 2023
Elevated cerebrospinal fluid ubiquitin C-terminal hydrolase-L1 levels correlate with phenotypic severity and therapeutic response in Niemann-Pick disease, type C1Niamh X Cawley, Spencer Giddens, Nicole M Farhat, et al.
The Lancet. Neurology|September 20, 2025
Research priorities for the neuronal ceroid lipofuscinosesErika F Augustine, Nadia Moore, Nicolas J Abreu, et al.
Pageof 27

Showing results (171-180 of 265) with videos related to

Sort By:
Pageof 27
Pediatrics|January 2, 2009
Advances in the treatment of fragile X syndromeRandi J Hagerman, Elizabeth Berry-Kravis, Walter E Kaufmann, et al.
Journal of Neurodevelopmental Disorders|June 30, 2010
Aging in fragile X syndromeAgustini Utari, Evan Adams, Elizabeth Berry-Kravis, et al.
Frontiers in Genetics|June 6, 2018
Health Profiles of Mosaic Versus Non-mosaic <i>FMR1</i> Premutation Carrier Mothers of Children With Fragile X SyndromeMarsha R Mailick, Arezoo Movaghar, Jinkuk Hong, et al.
Journal of Neurodevelopmental Disorders|November 26, 2022
A randomized, controlled trial of ZYN002 cannabidiol transdermal gel in children and adolescents with fragile X syndrome (CONNECT-FX)Elizabeth Berry-Kravis, Randi Hagerman, Dejan Budimirovic, et al.
Brain Sciences|December 19, 2018
Best Practices in Fragile X Syndrome Treatment DevelopmentCraig A Erickson, Walter E Kaufmann, Dejan B Budimirovic, et al.
Neurology|February 26, 2020
Validation of the NIH Toolbox Cognitive Battery in intellectual disabilityRebecca H Shields, Aaron J Kaat, Forrest J McKenzie, et al.
Journal of Neurodevelopmental Disorders|January 25, 2025
A randomized, placebo-controlled, cross-over trial of ketamine in Rett syndromeKathleen Campbell, Jeffrey L Neul, David N Lieberman, et al.
Journal of Child and Adolescent Psychopharmacology|February 6, 2025
The Aberrant Behavior Checklist for Fragile X Syndrome: A Qualitative Clinician Evaluation of Content ValidityLindsay M Oberman, Elizabeth Berry-Kravis, Dejan B Budimirovic, et al.
Molecular Genetics and Metabolism|July 30, 2023
Elevated cerebrospinal fluid ubiquitin C-terminal hydrolase-L1 levels correlate with phenotypic severity and therapeutic response in Niemann-Pick disease, type C1Niamh X Cawley, Spencer Giddens, Nicole M Farhat, et al.
The Lancet. Neurology|September 20, 2025
Research priorities for the neuronal ceroid lipofuscinosesErika F Augustine, Nadia Moore, Nicolas J Abreu, et al.
Pageof 27